Effect of Calorie Restriction With or Without Exercise on Insulin Sensitivity, β-Cell Function, Fat Cell Size, and Ectopic Lipid in Overweight Subjects
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
OBJECTIVE—The purpose of this article was to determine the relationships among total body fat, visceral adipose tissue (VAT), fat cell size (FCS), ectopic fat deposition in liver (intrahepatic lipid [IHL]) and muscle (intramyocellular lipid [IMCL]), and insulin sensitivity index (Si) in healthy overweight, glucose-tolerant subjects and the effects of calorie restriction by diet alone or in conjunction with exercise on these variables. RESEARCH DESIGN AND METHODS—Forty-eight overweight volunteers were randomly assigned to four groups: control (100% of energy requirements), 25% calorie restriction (CR), 12.5% calorie restriction +12.5% energy expenditure through structured exercise (CREX), or 15% weight loss by a low-calorie diet followed by weight maintenance for 6 months (LCD). Weight, percent body fat, VAT, IMCL, IHL, FCS, and Si were assessed at baseline and month 6. RESULTS—At baseline, FCS was related to VAT and IHL (P < 0.05) but not to IMCL. FCS was also the strongest determinant of Si (P < 0.01). Weight loss at month 6 was 1 ± 1% (control, mean ± SE), 10 ± 1% (CR), 10 ± 1% (CREX), and 14 ± 1% (LCD). VAT, FCS, percent body fat, and IHL were reduced in the three intervention groups (P < 0.01), but IMCL was unchanged. Si was increased at month 6 (P = 0.05) in the CREX (37 ± 18%) and LCD (70 ± 34%) groups (P < 0.05) and tended to increase in the CR group (40 ± 20%, P = 0.08). Together the improvements in Si were related to loss in weight, fat mass, and VAT, but not IHL, IMCL, or FCS. CONCLUSIONS—Large adipocytes lead to lipid deposition in visceral and hepatic tissues, promoting insulin resistance. Calorie restriction by diet alone or with exercise reverses this trend.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Likewise, histological improvement of different MASLD components depended on the amount of weight loss: Whereas about 5-7 % of weight loss already lead to a reduction in liver lipid content in 65 % of people with MASLD, MASH resolution (defined as the absence of hepatocellular ballooning) was achieved in 64 % by a 7-10 % decrease in body weight [46][47][48][49].”
From Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease? (2024) · cites this paper as [46]
In the citing paper
“Although short-term dietary restriction has metabolic effects in humans such as lowering metabolic rate (Heilbronn et al., 2006), improving insulin sensitivity (Larson-Meyer et al., 2006; Lim et al., 2011) and reducing cardiovascular risk factors (Lefevre et al., 2009)”
From Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans (2011) · cites this paper as Larson-Meyer et al., 2006
In the citing paper
“as was calorie restriction, although this effect was mainly attributed to a reduction in body weight (Larson-Meyer et al., 2006; Lim et al., 2011).”
From Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans (2011) · cites this paper as Larson-Meyer et al., 2006
In the citing paper
“Reducing caloric intake to ~75-80% of baseline energy requirements has been shown to maintain insulin sensitivity in overweight middle-aged humans.114, 115”
From Hormonal and Metabolic Changes of Aging and the Influence of Lifestyle Modifications (2021) · cites this paper as [114]
In the citing paper
“The increase in fat mass is one of the major determinants of insulin resistance (Larson-Meyer et al., 2006).”
From Mitochondrial Activity and Dynamics Changes Regarding Metabolism in Ageing and Obesity (2017) · cites this paper as Larson-Meyer et al., 2006
Citations
Cites
Ross, R., Dagnone, D., Jones, P. J. H., Smith, H., Paddags, A., Hudson, R., & Janssen, I. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-2-200007180-00008 · Cited by 1,435
Krssak, M., Falk Petersen, K., Dresner, A., DiPietro, L., Vogel, S. M., Rothman, D. L., Shulman, G. I., & Roden, M. (1999) · Diabetologia · doi:10.1007/s001250051123 · Cited by 1,264
Goodpaster, B. H. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.12.5755 · Cited by 1,194 · cited 1×
“Many other factors, including lipid droplet size, location of lipid droplets relative to mitochondria, and muscle oxidative capacity, are all potential determinants of insulin resistance (15,48,54).”
BackgroundSkeletal Muscle Triglyceride Levels Are Inversely Related to Insulin Action
Pan, D. A., Lillioja, S., Kriketos, A. D., Milner, M. R., Baur, L. A., Bogardus, C., Jenkins, A. B., & Storlien, L. H. (1997) · Diabetes · doi:10.2337/diab.46.6.983 · Cited by 1,179
Skeletal muscle triglyceride levels are inversely related to insulin action
Pan, D. A., Lillioja, S., Kriketos, A. D., Milner, M. R., Baur, L. A., Bogardus, C., Jenkins, A. B., & Storlien, L. H. (1997) · Diabetes · doi:10.2337/diabetes.46.6.983 · Cited by 1,179
Heilbronn, L. K., de Jonge, L., Frisard, M. I., DeLany, J. P., Larson-Meyer, D. E., Rood, J., Nguyen, T., Martin, C. K., Volaufova, J., Most, M. M., et al. (2006) · JAMA · doi:10.1001/jama.295.13.1539 · Cited by 969
Self-citationPetersen, K. F., Dufour, S., Befroy, D., Lehrke, M., Hendler, R. E., & Shulman, G. I. (2005) · Diabetes · doi:10.2337/diabetes.54.3.603 · Cited by 911
Perseghin, G., Scifo, P., De Cobelli, F., Pagliato, E., Battezzati, A., Arcelloni, C., Vanzulli, A., Testolin, G., Pozza, G., Del Maschio, A., et al. (1999) · Diabetes · doi:10.2337/diabetes.48.8.1600 · Cited by 877
Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy
Petersen, K. F., Oral, E. A., Dufour, S., Befroy, D., Ariyan, C., Yu, C., Cline, G. W., DePaoli, A. M., Taylor, S. I., Gorden, P., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215001 · Cited by 800 · cited 1×
“This finding prompts speculation that impaired adipogenesis may be the primary defect in insulin resistance, and the hypothesis is supported by findings that humans with partial or complete loss of adipose tissue are extremely insulin resistant (40), that surgical replacement of adipose stores in the fatless mouse res…”
ResultWeyer, C., Foley, J. E., Bogardus, C., Tataranni, P. A., & Pratley, R. E. (2000) · Diabetologia · doi:10.1007/s001250051560 · Cited by 799
Jacob, S., Machann, J., Rett, K., Brechtel, K., Volk, A., Renn, W., Maerker, E., Matthaei, S., Schick, F., Claussen, C. D., et al. (1999) · Diabetes · doi:10.2337/diabetes.48.5.1113 · Cited by 643
Havel, P. J. (2004) · Diabetes · doi:10.2337/diabetes.53.2007.s143 · Cited by 626
Effects of weight loss on regional fat distribution and insulin sensitivity in obesity.
Goodpaster, B. H., Kelley, D. E., Wing, R. R., Meier, A., & Thaete, F. L. (1999) · Diabetes · doi:10.2337/diabetes.48.4.839 · Cited by 608
Smith, S. R., Lovejoy, J. C., Greenway, F., Ryan, D., deJonge, L., de la Bretonne, J., Volafova, J., & Bray, G. A. (2001) · Metabolism · doi:10.1053/meta.2001.21693 · Cited by 596
Self-citationSubdivisions of subcutaneous abdominal adipose tissue and insulin resistance
Kelley, D. E., Thaete, F. L., Troost, F., Huwe, T., & Goodpaster, B. H. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.278.5.e941 · Cited by 538 · cited 1×
“Although total fat mass and subcutaneous abdominal adipose tissue (SAT) are associated with insulin resistance, visceral adipose tissue (VAT) is generally considered to be the most significant determinant (4).”
BackgroundIntramuscular lipid content is increased in obesity and decreased by weight loss
Goodpaster, B. H., Theriault, R., Watkins, S. C., & Kelley, D. E. (2000) · Metabolism · doi:10.1016/s0026-0495(00)80010-4 · Cited by 526 · cited 1×
“Muscle lipid content is reduced with severe weight reduction ( 15–24%) in obese and morbidly obese individuals undergoing an 800-kcal diet (12) or gastric bypass surgery (13).”
BackgroundSinha, R., Dufour, S., Petersen, K. F., LeBon, V., Enoksson, S., Ma, Y.-Z., Savoye, M., Rothman, D. L., Shulman, G. I., & Caprio, S. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1022 · Cited by 493
Failure of adipocyte differentiation causes type II diabetes mellitus?
Danforth, E. (2000) · Nature Genetics · doi:10.1038/79111 · Cited by 487
Insulin Resistance in Morbid Obesity
Greco, A. V., Mingrone, G., Giancaterini, A., Manco, M., Morroni, M., Cinti, S., Granzotto, M., Vettor, R., Camastra, S., & Ferrannini, E. (2002) · Diabetes · doi:10.2337/diabetes.51.1.144 · Cited by 442 · cited 1×
“Muscle lipid content is reduced with severe weight reduction ( 15–24%) in obese and morbidly obese individuals undergoing an 800-kcal diet (12) or gastric bypass surgery (13).”
BackgroundRyysy, L., Häkkinen, A. M., Goto, T., Vehkavaara, S., Westerbacka, J., Halavaara, J., & Yki-Järvinen, H. (2000) · Diabetes · doi:10.2337/diabetes.49.5.749 · Cited by 431 · cited 1×
“Liver lipid content has previously been reported to correlate with measures of whole-body insulin sensitivity in individuals with and without diabetes (30,34,35,38,49), but this relationship is difficult to explain mechanistically because most ingested (or infused) glucose is taken up by muscle.”
BackgroundBoston, R. C., Stefanovski, D., Moate, P. J., Sumner, A. E., Watanabe, R. M., & Bergman, R. N. (2003) · Diabetes Technology & Therapeutics · doi:10.1089/152091503322641060 · Cited by 431
Goodpaster, B. H., Katsiaras, A., & Kelley, D. E. (2003) · Diabetes · doi:10.2337/diabetes.52.9.2191 · Cited by 390
Simoneau, J., Colberg, S. R., Thaete, F. L., & Kelley, D. E. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.2.7781930 · Cited by 362 · cited 1×
“Many other factors, including lipid droplet size, location of lipid droplets relative to mitochondria, and muscle oxidative capacity, are all potential determinants of insulin resistance (15,48,54).”
BackgroundHeilbronn, L. K., Rood, J., Janderova, L., Albu, J. B., Kelley, D. E., Ravussin, E., & Smith, S. R. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031410 · Cited by 307
Self-citationDrenick, E. J., Simmons, F., & Murphy, J. F. (1970) · New England Journal of Medicine · doi:10.1056/nejm197004092821502 · Cited by 291
Luyckx, F., Lefebvre, P. J., & Scheen, A. J. (2000) · PubMed · Cited by 275
Tiikkainen, M., Bergholm, R., Vehkavaara, S., Rissanen, A., Häkkinen, A.-M., Tamminen, M., Teramo, K., & Yki-Järvinen, H. (2003) · Diabetes · doi:10.2337/diabetes.52.3.701 · Cited by 271
Virkamäki, A., Korsheninnikova, E., Seppälä-Lindroos, A., Vehkavaara, S., Goto, T., Halavaara, J., Häkkinen, A.-M., & Yki-Järvinen, H. (2001) · Diabetes · doi:10.2337/diabetes.50.10.2337 · Cited by 260
Plasma cytokine profiles in elderly humans
Forsey, R. J., Thompson, J. M., Ernerudh, J., Hurst, T. L., Strindhall, J., Johansson, B., Nilsson, B.-O., & Wikby, A. (2003) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(03)00025-3 · Cited by 249
Forouhi, N. G., Jenkinson, G., Thomas, E. L., Mullick, S., Mierisova, S., Bhonsle, U., McKeigue, P. M., & Bell, J. D. (1999) · Diabetologia · doi:10.1007/s001250051250 · Cited by 242
van Loon, L. J. C., Koopman, R., Manders, R., van der Weegen, W., van Kranenburg, G. P., & Keizer, H. A. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00464.2003 · Cited by 239
Thamer, C., Machann, J., Bachmann, O., Haap, M., Dahl, D., Wietek, B., Tschritter, O., Niess, A., Brechtel, K., Fritsche, A., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021674 · Cited by 229
Dengel, D. R., Pratley, R. E., Hagberg, J. M., Rogus, E. M., & Goldberg, A. P. (1996) · Journal of Applied Physiology · doi:10.1152/jappl.1996.81.1.318 · Cited by 189
Banerji, M. A., Buckley, M.-C., Chaiken, R. L., Gordon, D., Lebovitz, H. E., & Kral, J. G. (1995) · PubMed · Cited by 180
You, T., Yang, R., Lyles, M. F., Gong, D., & Nicklas, B. J. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00419.2004 · Cited by 173
Evidence of impaired adipogenesis in insulin resistance
Yang, X., Jansson, P.-A., Nagaev, I., Jack, M. M., Carvalho, E., Sunnerhagen, K. S., Cam, M. C., Cushman, S. W., & Smith, U. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.03.152 · Cited by 170
Seppala-Lindroos, A. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.7.3023 · Cited by 168
Liver‐Fat Accumulation and Insulin Resistance in Obese Women with Previous Gestational Diabetes
Tiikkainen, M., Tamminen, M., Häkkinen, A., Bergholm, R., Vehkavaara, S., Halavaara, J., Teramo, K., Rissanen, A., & Yki‐Järvinen, H. (2002) · Obesity Research · doi:10.1038/oby.2002.118 · Cited by 162
Exercise Is Required for Visceral Fat Loss in Postmenopausal Women with Type 2 Diabetes
Giannopoulou, I., Ploutz-Snyder, L. L., Carhart, R., Weinstock, R. S., Fernhall, B., Goulopoulou, S., & Kanaley, J. A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1782 · Cited by 159
Effects of Weight Loss and Physical Activity on Muscle Lipid Content and Droplet Size
He, J., Goodpaster, B. H., & Kelley, D. E. (2004) · Obesity Research · doi:10.1038/oby.2004.92 · Cited by 154
Kautzky-Willer, A., Krssak, M., Winzer, C., Pacini, G., Tura, A., Farhan, S., Wagner, O., Brabant, G., Horn, R., Stingl, H., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.2.244 · Cited by 150
Colombo, C., Cutson, J. J., Yamauchi, T., Vinson, C., Kadowaki, T., Gavrilova, O., & Reitman, M. L. (2002) · Diabetes · doi:10.2337/diabetes.51.9.2727 · Cited by 147 · cited 1×
“This finding prompts speculation that impaired adipogenesis may be the primary defect in insulin resistance, and the hypothesis is supported by findings that humans with partial or complete loss of adipose tissue are extremely insulin resistant (40), that surgical replacement of adipose stores in the fatless mouse res…”
ResultGoto, T., Onuma, T., Takebe, K., & Kral, J. G. (1995) · PubMed · Cited by 145
Muscle-associated triglyceride measured by computed tomography and magnetic resonance spectroscopy
Larson‐Meyer, D. E., Smith, S. R., Heilbronn, L. K., Kelley, D. E., Ravussin, E., Newcomer, B. R., & The Look AHEAD Adipose Research Group (2006) · Obesity · doi:10.1038/oby.2006.10 · Cited by 111
Self-citationImpact of Intra-Abdominal Fat and Age on Insulin Sensitivity and β-Cell Function
Utzschneider, K. M., Carr, D. B., Hull, R. L., Kodama, K., Shofer, J. B., Retzlaff, B. M., Knopp, R. H., & Kahn, S. E. (2004) · Diabetes · doi:10.2337/diabetes.53.11.2867 · Cited by 109
Malenfant, P., Tremblay, A., Doucet, É., Imbeault, P., Simoneau, J., & Joanisse, D. R. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.4.e632 · Cited by 79
Okura, T., Nakata, Y., Lee, D. J., Ohkawara, K., & Tanaka, K. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803013 · Cited by 74
Matsumoto, K., Sera, Y., Abe, Y., Ueki, Y., Tominaga, T., & Miyake, S. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00198-9 · Cited by 70
Perseghin, G., Scifo, P., Danna, M., Battezzati, A., Benedini, S., Meneghini, E., Del Maschio, A., & Luzi, L. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00127.2002 · Cited by 70
NISKANEN, L. K., Uusitupa, M. I. J., Sarlund, H., Siitonen, O., Paljärvi, L., & Laakso, M. (1996) · PubMed · Cited by 65
Stettler, R., Ith, M., Acheson, K. J., Décombaz, J., Boesch, C., Tappy, L., & Binnert, C. (2005) · Diabetes Care · doi:10.2337/diacare.28.6.1404 · Cited by 62
Franssila-Kallunki, A., Rissanen, A., Ekstrand, A., Ollus, A., & Groop, P. (1992) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/56.1.247s · Cited by 35
Liver triglycerides and metabolism.
Björntorp, P. A. (1995) · PubMed · Cited by 28
Lovejoy, J. C., Smith, S. R., Bray, G. A., Veldhuis, J. D., Rood, J. C., & Tulley, R. T. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90142-6 · Cited by 26
Self-citation
Research works printed but not linked: 1
- Hwang JH, Stein DT, Balent B, Barillas L, Tonelli J, Rosenbaum M, Hawkins M: Simultaneous quantitative assessment of intrahepatic triglycerides (IHTG) and intramyocellular lipids (IMCL) using 1H MRS in non-diabetic subjects: relationship to insulin sensitivity. In Proceeedings of the International Society for Magnetic Resonance in Medicine, Honolulu, Hawaii. International Society for Magnetic Resonance in Medicine, 2002
Cited by
Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012) · Hepatology · doi:10.1002/hep.25762 · Cited by 3,803
Garvey, W. T., Mechanick, J. I., Brett, E. M., Garber, A. J., Hurley, D. L., Jastreboff, A. M., Nadolsky, K., Pessah-Pollack, R., & Plodkowski, R. (2016) · Endocrine Practice · doi:10.4158/ep161365.gl · Cited by 1,914
Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.04.001 · Cited by 1,775
The intersection between aging and cardiovascular disease
North, B. J., & Sinclair, D. A. (2012) · Circulation Research · doi:10.1161/circresaha.111.246876 · Cited by 1,585
Timmers, S., Konings, E., Bilet, L., Houtkooper, R. H., van de Weijer, T., Goossens, G. H., Hoeks, J., van der Krieken, S., Ryu, D., Kersten, S., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.10.002 · Cited by 1,320
Metadata
- Authors
- Larson-Meyer, D. E., Heilbronn, L. K., Redman, L. M., Newcomer, B. R., Frisard, M. I., Anton, S., Smith, S. R., Alfonso, A., Ravussin, E., & the Pennington CALERIE Team
- Affiliations
- Pennington Biomedical Research Center, Baton Rouge, Louisiana
- Pennington Biomedical Research Center (US)
- University of Alabama at Birmingham (US)
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2006-06-01
- Volume
- 29
- Issue
- 6
- Pages
- 1337-1344
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2677812
- OpenAlex
- W2129345771
- Cited by
- 504
- References
- 54
- Citations by year
- 2026: 9 · 2025: 19 · 2024: 14 · 2023: 22 · 2022: 20 · 2021: 18 · 2020: 26 · 2019: 20 · 2018: 21 · 2017: 37 · 2016: 34 · 2015: 33 · 2014: 26 · 2013: 31 · 2012: 25
- FWCI
- 19.02
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Funders
- National Health and Medical Research Council (349553)
- National Institute on Aging (U01AG020478, U01-AG20478)
- National Institute of Diabetes and Digestive and Kidney Diseases (K01DK062018, P30DK072476)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- caloric restriction, physical activity, insulin sensitivity, beta-cell function, adipocyte size, visceral adipose tissue, intrahepatic lipid, intramyocellular lipid, ectopic fat deposition, overweight, weight loss, hypocaloric diet, insulin resistance
- MeSH terms
- Adipose Tissue, Basal Metabolism, Body Weight, Diet, Reducing, Energy Metabolism, Humans, Insulin, Islets of Langerhans, Lipids, Viscera, Exercise, Body Mass Index, Cell Size, Overweight
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.